MedPath
HSA Approval

APO-PERPHENAZINE TABLET 8 mg

SIN00437P

APO-PERPHENAZINE TABLET 8 mg

APO-PERPHENAZINE TABLET 8 mg

April 27, 1988

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N05AB03

perphenazine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

PERPHENAZINE

8 mg

Perphenazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-PERPHENAZINE TABLET 8 mg - HSA Approval | MedPath